(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Critical Illness D016638 13 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Encephalopathy, Bovine Spongiform D016643 2 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Diabetic Ketoacidosis D016883 16 associated lipids
Liver Failure D017093 5 associated lipids
Hyperandrogenism D017588 5 associated lipids
Glucose Intolerance D018149 13 associated lipids
Adenocarcinoma, Clear Cell D018262 1 associated lipids
Placenta, Retained D018457 3 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Lomas AJ et al. Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate)/collagen hybrid scaffolds for tissue engineering applications. 2013 Tissue Eng Part C Methods pmid:23281705
Sato T et al. Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. 1998 Tohoku J. Exp. Med. pmid:9710942
Ally AI et al. Trimethyltin as a selective adrenal chemosympatholytic agent in vivo: effect precedes both clinical and histopathological evidence of toxicity. 1986 Toxicology pmid:3726895
Cahill GF and Veech RL Ketoacids? Good medicine? 2003 Trans. Am. Clin. Climatol. Assoc. pmid:12813917
Sasi P et al. Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions. 2006 Trans. R. Soc. Trop. Med. Hyg. pmid:16257025
Whisson ME et al. Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. 1993 Transfus Med pmid:8374698
Laird MD et al. Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels. 2013 Transl Stroke Res pmid:24323418
Yamaguchi M et al. Evaluation of temporary portal vein arterialization: the minimum arterialized blood flow for maintaining liver viability. 1990 Transpl. Int. pmid:2271087
Igea J et al. Evaluation of beta-oxidation parameters and mitochondrial redox state as early markers of hepatic function in hepatic transplantation. 1999 Transplant. Proc. pmid:10500662
Kitabayashi K et al. Arterial ketone body ratio in clinical liver transplantation. 1998 Transplant. Proc. pmid:9865382